Upregulation of S100A6 and its relation with CD34+ cells apoptosis in high-risk myelodysplastic syndromes patients

Collectively, S100A6 may be a potential marker of CD34 cells in high-risk patients with MDS and may participate in the pathological behaviors of CD34 cells, such as evasion of apoptosis. Thus, S100A6 may be a potential target for eliminating minimal residual disease.